Member Exclusive

Merck Serono in CAR-T alliance

The cohort of companies developing products for treating cancer with genetically engineered T-cells has increased with the announcement that Merck Serono and Intrexon Corp will collaborate to generate new drug candidates using the technology.

Thumb victoria 50   1
Mar 31, 2015

Please sign in or register for FREE

No comments yet.